Healthcare provider profile · identity verified

Steven We Kin Lee, MD

Family Practice · WOODLAND HILLS, CA · NPI 1073661906

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	584	202
Amlodipine Besylate	Amlodipine Besylate	418	133
Lisinopril	Lisinopril	302	100
Levothyroxine Sodium	Levothyroxine Sodium	240	72
Atenolol	Atenolol	206	63
Losartan Potassium	Losartan Potassium	200	64
Rosuvastatin Calcium	Rosuvastatin Calcium	196	65
Simvastatin	Simvastatin	174	58
Metformin Hcl	Metformin Hcl	169	61
Hydrochlorothiazide	Hydrochlorothiazide	166	53
Omeprazole	Omeprazole	143	61
Tamsulosin Hcl	Tamsulosin Hcl	126	43
Gabapentin	Gabapentin	122	47
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	103	22
Glipizide	Glipizide	102	35
Albuterol Sulfate Hfa	Albuterol Sulfate	98	49
Metoprolol Tartrate	Metoprolol Tartrate	93	31
Terazosin Hcl	Terazosin Hcl	90	31
Pantoprazole Sodium	Pantoprazole Sodium	85	24
Allopurinol	Allopurinol	82	25
Alendronate Sodium	Alendronate Sodium	81	31
Metformin Hcl Er	Metformin Hcl	78	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	23
Potassium Chloride	Potassium Chloride	73	26
Triamcinolone Acetonide	Triamcinolone Acetonide	58	44
Pradaxa	Dabigatran Etexilate Mesylate	56	19
Prednisone	Prednisone	56	51
Trazodone Hcl	Trazodone Hcl	56	19
Furosemide	Furosemide	55	26
Meloxicam	Meloxicam	54	31
Finasteride	Finasteride	53	15
Lorazepam	Lorazepam	50	13
Spiriva Respimat	Tiotropium Bromide	49	suppressed
Carvedilol	Carvedilol	48	14
Famotidine	Famotidine	47	21
Cephalexin	Cephalexin	41	40
Spironolactone	Spironolactone	40	12
Clopidogrel	Clopidogrel Bisulfate	38	14
Ezetimibe	Ezetimibe	38	12
Warfarin Sodium	Warfarin Sodium	36	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	34	32
Hydralazine Hcl	Hydralazine Hcl	34	13
Arexvy	Rsvpref3 Antigen/As01e/Pf	33	33
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Alvesco	Ciclesonide	29	13
Amoxicillin	Amoxicillin	29	25
Hydrocortisone	Hydrocortisone	27	12
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Ipratropium Bromide	Ipratropium Bromide	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Clonazepam	Clonazepam	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Ibuprofen	Ibuprofen	22	11
Sertraline Hcl	Sertraline Hcl	22	suppressed
Colchicine	Colchicine	21	11
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Mupirocin	Mupirocin	20	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Ibandronate Sodium	Ibandronate Sodium	19	suppressed
Ondansetron Odt	Ondansetron	19	12
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Metoprolol Succinate	Metoprolol Succinate	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	17	17
Benazepril Hcl	Benazepril Hcl	17	suppressed
Digoxin	Digoxin	17	suppressed
Duloxetine Hcl	Duloxetine Hcl	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Eliquis	Apixaban	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Humulin R	Insulin Regular, Human	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Estradiol	Estradiol	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Montelukast Sodium	Montelukast Sodium	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error